{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-025326","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.323588+00:00","generated_at":"2026-06-02T03:31:44.942957+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SANUWAVE Q1 revenue up 53% to $5.8M; operating loss narrows to $1.1M; reaffirms FY 2024 growth guidance of 50%","bullets":["Revenue $5.8M (+53% YoY); gross margin 73% (+600bps); UltraMist consumables revenue $4.1M (+64%).","Operating loss $1.1M vs $2.0M in Q1 2023; net loss $4.5M includes $3.9M non-cash derivative charge.","Adjusted EBITDA loss improved to $59K from $1.8M loss YoY.","Guidance: Q2 2024 revenue growth 45-55% YoY; FY 2024 revenue growth of 50% reiterated.","Sold 43 UltraMist systems in Q1 (up from 28 in Q1 2023, down from 79 in Q4 2023)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-025326","json":"https://secwatch.observer/filing/0001140361-24-025326.json","markdown":"https://secwatch.observer/filing/0001140361-24-025326.md","text":"https://secwatch.observer/filing/0001140361-24-025326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/0001140361-24-025326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/ef20028815_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T03:31:44.942957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5639ddcb80d45e7ee66848f82410fe21605e93bf","claim":"SANUWAVE Health, Inc. reported first quarter ended March 31, 2024 results: revenue $5.8 million, net income $4.5 million. Guidance reaffirmed.","evidence_excerpt":"in such filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ef20028815_99-1.htm EXHIBIT 99.1 Exhibit 99.1 SANUWAVE Announces Q1 FY2024 Financial Results Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/0001140361-24-025326-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$5.8 million"},{"label":"Net income","value":"$4.5 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}